Peptide-guided adaptor-CAR T-Cell therapy for the treatment of SSTR2-expressing neuroendocrine tumors

Somatostatin receptor type 2 (SSTR2) is one of the five subtypes of somatostatin receptors and is overexpressed on the surface of most gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs), pituitary tumors, paraganglioma, and meningioma, as well as hepatocellular carcinoma and breast cancer. Ch...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Christian Pellegrino, Nicholas Favalli, Laura Volta, Ramon Benz, Sara Puglioli, Gabriele Bassi, Kathrin Zitzmann, Christoph Josef Auernhammer, Svenja Nölting, Chiara F. Magnani, Dario Neri, Felix Beuschlein, Markus G. Manz
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Taylor & Francis Group 2024-12-01
Serie:	OncoImmunology
Ämnen:	Adaptor-CAR T-cell neuroendocrine tumors Octo-fluo bispecific adaptor SSTR2
Länkar:	https://www.tandfonline.com/doi/10.1080/2162402X.2024.2412371
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!